BRPI0408899A - compostos benzo[1,2,5]tiadiazol - Google Patents

compostos benzo[1,2,5]tiadiazol

Info

Publication number
BRPI0408899A
BRPI0408899A BRPI0408899-9A BRPI0408899A BRPI0408899A BR PI0408899 A BRPI0408899 A BR PI0408899A BR PI0408899 A BRPI0408899 A BR PI0408899A BR PI0408899 A BRPI0408899 A BR PI0408899A
Authority
BR
Brazil
Prior art keywords
benzo
thiadiazole compounds
compounds
cck2
thiadiazole
Prior art date
Application number
BRPI0408899-9A
Other languages
English (en)
Inventor
Brett Allison
Laura C Mcatee
Victor K Phuong
Michael H Rabinowitz
Nigel P Shankley
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0408899A publication Critical patent/BRPI0408899A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMPOSTOS BENZO¢1,2,5!TIADIAZOL". A presente invenção refere-se a certos compostos amidofenil-sulfanilamino-benzo¢1,2,5!tiadiazol que são moduladores de CCK2 úteis no tratamento de doenças mediadas por CCK2.
BRPI0408899-9A 2003-03-28 2004-03-26 compostos benzo[1,2,5]tiadiazol BRPI0408899A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45863803P 2003-03-28 2003-03-28
PCT/US2004/009589 WO2005012275A2 (en) 2003-03-28 2004-03-26 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators

Publications (1)

Publication Number Publication Date
BRPI0408899A true BRPI0408899A (pt) 2006-04-18

Family

ID=34115280

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408899-9A BRPI0408899A (pt) 2003-03-28 2004-03-26 compostos benzo[1,2,5]tiadiazol

Country Status (20)

Country Link
US (2) US7241759B2 (pt)
EP (1) EP1675837A2 (pt)
JP (1) JP2006528241A (pt)
KR (1) KR20050119666A (pt)
CN (1) CN1829704A (pt)
AU (1) AU2004261547A1 (pt)
BR (1) BRPI0408899A (pt)
CA (1) CA2520546A1 (pt)
CO (1) CO5700819A2 (pt)
CR (1) CR8009A (pt)
EC (1) ECSP056057A (pt)
IS (1) IS8042A (pt)
MX (1) MXPA05010484A (pt)
NO (1) NO20055002L (pt)
NZ (1) NZ542491A (pt)
RS (1) RS20050733A (pt)
RU (1) RU2005133206A (pt)
UA (1) UA82872C2 (pt)
WO (1) WO2005012275A2 (pt)
ZA (1) ZA200508732B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
US7297816B2 (en) 2004-09-24 2007-11-20 Janssen Pharmaceutica N.V. Sulfonamide compounds
US7599588B2 (en) * 2005-11-22 2009-10-06 Vascular Imaging Corporation Optical imaging probe connector
EP1795198A1 (en) * 2005-12-09 2007-06-13 Hubrecht Laboratorium Treatment of Barret's esophagus
WO2008124518A1 (en) * 2007-04-03 2008-10-16 Janssen Pharmaceutica N.V. Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
EP2053052A1 (en) * 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
PE20120693A1 (es) 2009-06-29 2012-07-04 Agios Pharmaceuticals Inc Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
RU2532492C1 (ru) * 2013-01-28 2014-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ эндоскопического лечения гастродуоденальных язв
RU2693484C1 (ru) 2013-11-22 2019-07-03 СиЭль БАЙОСАЕНСИЗ ЭлЭлСи Антагонисты гастрина для лечения и профилактики остеопороза

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703995B1 (fr) 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
JP3999819B2 (ja) 1996-12-10 2007-10-31 ゼリア新薬工業株式会社 １，５―ベンゾジアセピン誘導体
WO2000078145A1 (en) * 1999-06-24 2000-12-28 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
GB0028702D0 (en) 2000-11-24 2001-01-10 Novartis Ag Organic compounds
JP2004529170A (ja) * 2001-05-07 2004-09-24 スミスクライン・ビーチャム・コーポレイション スルホンアミド
ITTO20020674A1 (it) 2002-07-26 2004-01-26 Rotta Research Lab Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico

Also Published As

Publication number Publication date
CR8009A (es) 2008-09-10
US20070276016A1 (en) 2007-11-29
US7550492B2 (en) 2009-06-23
CO5700819A2 (es) 2006-11-30
MXPA05010484A (es) 2006-03-10
NO20055002L (no) 2005-12-14
WO2005012275A3 (en) 2006-05-11
CA2520546A1 (en) 2005-02-10
CN1829704A (zh) 2006-09-06
NO20055002D0 (no) 2005-10-27
NZ542491A (en) 2009-04-30
KR20050119666A (ko) 2005-12-21
ZA200508732B (en) 2007-04-25
RU2005133206A (ru) 2006-05-10
UA82872C2 (en) 2008-05-26
US7241759B2 (en) 2007-07-10
ECSP056057A (es) 2006-01-27
US20040224983A1 (en) 2004-11-11
RS20050733A (sr) 2007-06-04
EP1675837A2 (en) 2006-07-05
IS8042A (is) 2005-09-23
JP2006528241A (ja) 2006-12-14
AU2004261547A1 (en) 2005-02-10
WO2005012275A2 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
BRPI0413449A (pt) compostos de quinoxalina
BRPI0410711A (pt) novos compostos
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
BRPI0516027A (pt) compostos de sulfonamida
BRPI0417543A (pt) quinolinas úteis no tratamento de doença cardiovascular
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
BRPI0414598A (pt) indóis substituìdos
BRPI0411897A (pt) pirroldihidroisoquinolinas como inibidores de pde10
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
BR0113286A (pt) Pirazóis substituìdos
TW200509892A (en) Novel aminobenzophenone compounds
UA83691C2 (ru) Применение замещенных 2-аминотетралинов для упреждающего лечения болезни паркинсона
BRPI0417992A (pt) método para purificar fsh
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
BRPI0413820A (pt) derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
BRPI0412843A (pt) lactamas substituìdas e uso das mesmas como agentes anticáncer
BRPI0407913A (pt) antagonistas receptores de ccr-3
MXPA04005079A (es) Variantes del dominio c2 del factor viii.
BR0115996A (pt) Sulfamidotienopirimidinas
CR8009A (es) Compuestos benzo[1,2,5] tiadiazoles
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
IL156170A0 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
BR0317249A (pt) Método de preparar compostos de aminocianopiridina tricìclica
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
BR9807312A (pt) Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 7A E 8A ANUIDADES.